Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.8mm RC, SLA? 8mm, Ti, Loxim: medical device reports filed with FDA

4,746 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

4,746
device reports naming the brand
0% of all MAUDE reports · about 695 a year
859
reports, 12 months to August 2026
1,241 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 4,746 reports that name the brand "BL, ? 4.8mm RC, SLA? 8mm, Ti, Loxim" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

859 reports arrived in the 12 months to August 2026, down 31% from 1,241 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (91.7%), loss of osseointegration (7.5%) and fracture (0.4%). The patient problems coded most often are fibrosis, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0151301Sep 2021: 24Oct 2021: 38Nov 2021: 28Dec 2021: 272022Jan 2022: 28Feb 2022: 25Mar 2022: 39Apr 2022: 28May 2022: 40Jun 2022: 27Jul 2022: 37Aug 2022: 15Sep 2022: 24Oct 2022: 43Nov 2022: 59Dec 2022: 402023Jan 2023: 22Feb 2023: 1Mar 2023: 14Apr 2023: 71May 2023: 78Jun 2023: 81Jul 2023: 99Aug 2023: 78Sep 2023: 80Oct 2023: 99Nov 2023: 125Dec 2023: 1392024Jan 2024: 90Feb 2024: 102Mar 2024: 65Apr 2024: 149May 2024: 125Jun 2024: 99Jul 2024: 100Aug 2024: 49Sep 2024: 133Oct 2024: 62Nov 2024: 80Dec 2024: 1302025Jan 2025: 104Feb 2025: 55Mar 2025: 106Apr 2025: 62May 2025: 0Jun 2025: 301Jul 2025: 74Aug 2025: 134Sep 2025: 122Oct 2025: 59Nov 2025: 81Dec 2025: 782026Jan 2026: 91Feb 2026: 64Mar 2026: 57Apr 2026: 64May 2026: 41Jun 2026: 59Jul 2026: 82Aug 2026: 61

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

05921,1842019: 7620192020: 17820202021: 32120212022: 40520222023: 88720232024: 1,18420242025: 1,17620252026: 5192026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%4,746
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report98.5%4,676
Voluntary report0%0
User facility report0%0
Distributor report1.5%70
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate4,35391.7%62.8%
Loss of osseointegration3547.5%22.4%
Fracturea broken bone170.4%1.6%
Difficult to insertthe device was hard to insert30.1%0.4%
Separation failure20%0.1%
Unstable20%0%
Unintended movement10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis65413.8%
Painpain, site not specified3266.9%
Inflammationinflammation2846%
Tissue damage1763.7%
Swelling/ edema1553.3%
Hemorrhage/blood loss/bleeding1192.5%
Numbnessnumbness350.7%
Failure of implant270.6%
Fistula230.5%
Hyperresponsive to stimuli210.4%
Abscessa collection of pus160.3%
Inadequate osseointegration90.2%
Hypersensitivity/allergic reaction60.1%
Increased sensitivity20%
Swellingswelling20%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.8mm RC, SLA? 8mm, Ti, LoximProduct code DZEAll MAUDE reports
Reports4,7463,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer98.5%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.8mm RC, SLA? 8mm, Ti, Loxim reports

How many FDA reports name BL, ? 4.8mm RC, SLA? 8mm, Ti, Loxim?

4,746 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 859 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (91.7%), loss of osseointegration (7.5%), fracture (0.4%), difficult to insert (0.1%) and separation failure (0%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (98.5%) and distributor reports (1.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.8mm RC, SLA? 8mm, Ti, Loxim was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.